Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases. [electronic resource]
Producer: 20210208Description: 899-909 p. digitalISSN:- 1744-8301
- Animals
- Female
- Humans
- Antineoplastic Agents, Alkylating -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor
- Brain Neoplasms -- secondary
- Breast Neoplasms -- metabolism
- Drug Evaluation, Preclinical
- Research Design
- Telomerase -- metabolism
- Temozolomide -- pharmacology
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.